NeoPharm Co. Ltd. | Mutual Funds
Mutual Funds that own NeoPharm Co. Ltd.
FTIF SICAV - Templeton Asian Smaller Companies Fund
318,017
4.26%
0
0.87%
06/30/2018
DFA Emerging Markets Core Equity Portfolio
46,801
0.63%
780
0.01%
04/30/2018
DFA Emerging Markets Small Cap Series
38,474
0.52%
0
0.02%
01/31/2018
Stichting Pensioenfonds ABP (Global Equity Portfolio)
10,979
0.15%
10,979
0%
03/31/2018
8,737
0.12%
-1,238
4.76%
04/30/2018
DFA Emerging Markets Social Core Equity Portfolio
2,235
0.03%
417
0.01%
04/30/2018
John Hancock II - Emerging Markets Fund
1,420
0.02%
0
0.01%
04/30/2018
DFA World (ex-US) Core Equity Portfolio
1,128
0.02%
0
0%
04/30/2018
Old Westbury Small & Mid Cap Fund
1,026
0.01%
0
0%
04/30/2018
Dimensional Funds ICVC - Emerging Markets Core Equity Fund
981
0.01%
363
0%
12/31/2017
| Address |
309-8 Techno 2-ro
Daejeon DE 34037
Korea, Republic Of
|
|
Employees
|
- |
| Website |
http://www.neopharm.co.kr |
| Updated |
09/14/2018 |
| NeoPharm Co., Ltd. engages in the development, manufacture and sale of cosmetics and pharmaceutical products. It operates through the Cosmetics and Pharmaceuticals business divisions. The Cosmetics division provides emulsified and functional skin care products for sensitive and dry skin, treatment of atopic dermatitis and psoriasis, and therapy for steroid side effects. |
